Fig. 2From: Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trialAn intravitreal dexamethasone 700 μg implant (from Turpin et al. [11])Back to article page